DOI: 10.36347/sasjm.2020.v06i09.002

Pages: 198-203

Introduction: COVID-19 is a multi-organ disease secondary to SARS-Cov-2 this infection may be responsible in some cases for severe acute respiratory syndrome. The clinical characteristics and management of patients with pulmonary tuberculosis (TB). with COVID-19 are not yet clear and have not been sufficiently studied. Patient and method: In this observation, we report a case of SARS-Cov-2 infection revealing pulmonary tuberculosis, our management experience and the clinical and evolutionary data of this case. Results: This is a 20-year-old patient with pulmonary tuberculosis and COVID-19 co-infection held in front of an evocative clinical radio panel, positive COVID-19 PCR test and GeneXpert in sputum also positive. The thoracic CT showed an extended frosted glass appearance (25%-50%) with multiple parenchymal condensations in favor of a CORADS 5, with presence of multiple nodular opacities sometimes excavated. The patient is put on protocol: Hydroxychloroquine + Azithromycin sulfate, associated with antibacillary treatment. The clinical evolution was marked by apyrexia at the end of the 3rd day of treatment with progressive improvement of his respiratory symptomatology. Conclusion: With the rapid spread of the COVID-19 pandemic, broader studies are needed to study the prognosis of tuberculosis –COVID-19.